Transurethral resection of superficial bladder cancer: Technically safe, oncologically anything but perfect

Journal of Urology

Volumn 174, Issue 6, 2005, Pages 2086-2087

  Grimm, M O ^a   Ackermann, R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; BCG VACCINE; UNCLASSIFIED DRUG;

BLADDER CANCER; BLADDER PERFORATION; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL TRIAL; CLONAL VARIATION; CYSTOGRAPHY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; EDITORIAL; EXTRAVASATION; FLUORESCENCE; FLUORESCENCE ENDOSCOPY; FOLLOW UP; HUMAN; MINIMAL RESIDUAL DISEASE; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SUPERFICIAL CANCER; SURGICAL TECHNIQUE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

EID: 27744585203     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000190537.95113.e4     Document Type: Editorial

References (9)

1. Skolariakos, A., Chrisofos, M., Ferakis, N., Papatsoris, A., Dellis, A. and Deliveliotis, C.: Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence. J Urol, 173: 1908, 2005
2. Zurkirchen, M. A., Sulser, T., Gaspert, A. and Hauri, D.: Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists. Urol Int, 72: 99, 2004
3. Herr, H. W.: The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol, 162: 74, 1999
4. Grimm, M.-O., Steinhoff, C., Simon, X., Spiegelhalder, P., Ackermann, R. and Vögeli, T. A.: Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol, 170: 433, 2003
5. Schmidbauer, J., Witjes, F., Schmeller, N., Donat, R., Susani, M., Marberger, M. et al: Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol, 171: 135, 2004
6. Jocham, D., Witjes, F., Wagner, S., Zeylemaker, B., von Morselaar, J. and Grimm, M.-O.: Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol, 174: 862, 2005
7. Filbeck, T., Pichlmeier, U., Knuechel, R., Wieland, W. F. and Rossler, W.: Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol, 168: 67, 2002
8. Riedl, C. R., Daniltchenko, D., Koenig, F., Simak, R., Loening, S. A. and Pfluegler, H.: Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol, 165: 1121, 2001
9. Duggan, B. J., Gray, S. B., McKnight, J. J., Watson, C. J., Johnston, S. R. and Williamson, K. E.: Oligoclonality in bladder cancer: the implication for molecular therapies. J Urol, 171: 419, 2004